AZMARDA 50

About AZMARDA 50 is a combination medication containing Sacubitril and Valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI). It works by simultaneously enhancing the protective natriuretic peptide system (via sacubitril) and blocking the harmful effects of the renin-angiotensin-aldosterone system (RAAS) (via valsartan). This dual mechanism leads to vasodilation, natriuresis, and reduction in cardiac remodeling, significantly improving outcomes in patients with chronic heart failure. This medication is primarily indicated for the treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adult patients. It has demonstrated superior efficacy compared to ACE inhibitors or ARBs alone in reducing the risk of cardiovascular death and heart failure hospitalizations. Careful initiation and monitoring are required, especially regarding blood pressure, renal function, and potassium levels. Uses Treatment of chronic heart failure with reduced ejection fraction (HFrEF) Reduction of cardiovascular death in HFrEF patients Reduction of heart failure hospitalizations in HFrEF patients Improvement of symptoms and physical limitations associated with HFrEF Directions For Use Take one tablet twice daily, with or without food, as directed by your physician. Benefits Significantly reduces the risk of cardiovascular death. Lowers the rate of heart failure hospitalizations. Improves symptoms and quality of life in heart failure patients. Offers a novel dual mechanism of action. Recommended by major heart failure guidelines. Provides superior efficacy compared to traditional therapies. Side Effects Hypotension (low blood pressure) Hyperkalemia (high potassium levels) Cough Dizziness or lightheadedness Renal impairment (worsening kidney function) Fatigue Nausea Diarrhea Angioedema (swelling of face, lips, tongue - rare but serious) Syncope (fainting) Anemia Hypoglycemia (low blood sugar) Safety Measures Alcohol - Alcohol may exacerbate hypotensive effects and dizziness. It is advisable to limit or avoid alcohol consumption. Pregnancy - Contraindicated during pregnancy. It can cause fetal harm or death. Discontinue immediately if pregnancy is detected. Breastfeeding - Not recommended during breastfeeding. It is unknown if it is excreted in human milk, but potential for serious adverse effects on the infant exists. Liver - Use with caution in patients with moderate liver impairment. Avoid use in severe liver impairment. Kidney - Dose adjustment is required in patients with moderate kidney impairment. Avoid use in severe kidney impairment or end-stage renal disease. Lung - Generally safe for lung conditions, but monitor for cough, which is a common side effect and may be confused with respiratory symptoms. Disclaimer MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment. Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub. Our goal is to complement, not replace, the essential doctor-patient relationship.